Document Detail


Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia ("accelerated" chronic lymphocytic leukemia) with aggressive clinical behavior.
MedLine Citation:
PMID:  20378568     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Background The concept of "accelerated" chronic lymphocytic leukemia (CLL) is frequently used by both pathologists and clinicians. However, neither histological criteria to define this form of CLL nor its clinical correlates and prognostic impact have been formally defined in large series of patients. DESIGN AND METHODS: Tissue biopsies from 100 patients with CLL were analyzed for the size of proliferation centers (PCs) and their proliferation rate as assessed by mitosis count and Ki-67 immunostaining. Histological patterns were correlated with main clinico-biological features and outcome. RESULTS: The suspicion of disease transformation was the main reason to carry out tissue biopsy, which was performed at a median time of 14 months (range, 0 to 204) from CLL diagnosis. The biopsy showed histological transformation to diffuse large B-cell lymphoma (DLBCL-t) in 22 cases. In the remaining 78 patients, the presence of expanded PCs (broader than a 20x field) and high proliferation rate (either >2.4 mitosis/PC or Ki-67>40%/PC) predicted poor outcome and were selected to define a highly proliferative group. Thus, 23 patients with either expanded PCs or high proliferation rate were considered as having "accelerated" CLL. These patients displayed particular features, including higher serum LDH levels and more frequently elevated ZAP-70 than "non-accelerated" cases. Median survival from biopsy of patients with "non-accelerated" CLL, "accelerated" CLL and DLBCL-t was 76, 34, and 4.3 months, respectively (p<0.001). Conclusions The presence of expanded PCs and/or highly active PCs identifies a group of patients with "accelerated" CLL characterized by an aggressive clinical behavior.
Authors:
Eva Giné; Antoni Martinez; Neus Villamor; Armando López-Guillermo; Mireia Camos; Daniel Martinez; Jordi Esteve; Xavier Calvo; Ana Muntañola; Pau Abrisqueta; Maria Rozman; Ciril Rozman; Francesc Bosch; Elias Campo; Emili Montserrat
Related Documents :
1997238 - Inflammatory response in retrieved noncemented porous-coated implants.
19624478 - Accuracy of who cd4 cell count criteria for virological failure of antiretroviral therapy.
1681668 - Peripheral lymphocyte subpopulations in recurrent aphthous ulceration.
15088298 - Cd4+ t-lymphocytopenia--a frequent finding in anti-ssa antibody seropositive patients w...
20067328 - Associations between the c677t and a1298c polymorphisms of mthfr and the efficacy and t...
3413648 - Long term follow-up study of the marsupialization technique for urethral diverticula in...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2010-4-7
Journal Detail:
Title:  Haematologica     Volume:  -     ISSN:  1592-8721     ISO Abbreviation:  -     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-4-9     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0417435     Medline TA:  Haematologica     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Institute of Hematology and Oncology, Hospital Clinic, Barcelona, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The majority of the in vitro erythroid expansion potential resides in CD34(-) cells, outweighing the...
Next Document:  Role of NOXA and its ubiquitination in proteasome inhibitor-induced apoptosis in chronic lymphocytic...